Routine mammograms offer insight into women's risk of cardiovascular disease

Could mammograms provide clues into a woman’s risk or developing cardiovascular disease? According to new research published in Circulation: Cardiovascular Imaging, yes, they can. 

The research used mammography screenings from more than 5,000 women to analyze whether breast arterial calcifications (BACs) visualized on imaging had any associations with atherosclerotic cardiovascular disease (ASCVD). 

“Currently, it is not the standard of care for breast arterial calcification visible on mammograms to be reported,” explained lead author of the study Carlos Iribarren, MD, research scientist at the Kaiser Permanente Northern California Division of Research in Oakland, California. “Some radiologists do include this information on their mammography reports, but it’s not required.” 

To examine the relationship between BAC and ASVCD, the researchers narrowed their subset down to 5,059 women aged 60-79 with no documented history of cardiovascular disease or breast cancer. BAC presence and quantity with hard ASCVD and global CVD was assessed on all exams. Researchers tracked the patient’s health via EHR systems for an average of 6.5 years to assess whether the women developed cardiovascular disease or experienced major cardiovascular events, such as strokes or heart attacks. 

A total of 155 ASCVD events and 427 global CVD events were identified during the research. The presence of BAC was detected in 26% of women. Compared to the women without BAC, patients with the arterial calcifications were 51% more likely to develop heart disease or have a stroke, and 23% more likely to be diagnosed with any cardiovascular disease, including heart disease, stroke, heart failure and diseases of the peripheral arteries. 

“We hope that our study will encourage an update of the guidelines for reporting breast arterial calcification from routine mammograms,” Iribarren said. “Our study has moved the needle toward recommending routine assessment and reporting of breast arterial calcification in postmenopausal women.” 

Iribarren noted that women aged 50-74 are currently recommended to have routine mammogram screenings every two years, so the added clinical information provided when BAC is reported comes with additional diagnostic information only, not additional expenses. 

You can view the detailed research in Circulation: Cardiovascular Imaging, which is a journal of the American Heart Association

More breast imaging content:

Mayo Clinic offers new guidance on supplemental screening of women with dense breasts

VIDEO: Should women wait to get mammograms after COVID vaccination?

Breast cancer is overdiagnosed in 15% of screenings

New research can help radiologists manage architectural distortion identified via DBT exams

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She joined Innovate Healthcare in 2021 and has since put her unique expertise to use in her editorial role with Health Imaging.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.